The short answer is no
Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (Liraglutide Effect and Action in Diabetes)-2 study
The timing and strength of those changes varied by participant, research dose, escalation schedule, and individual health factors
and has received grant funding from the National Institutes of Health Research, Alzheimers Research UK, the Wellcome Trust, UK Research and Innovation, Lundbeck, and SoseiHeptares
A woman from Louisiana claims she was prescribed the drugs by her doctor and experienced severe gastrointestinal side effects, including gastroparesis